---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-22-023229"
form_type: "8-K"
ticker: "OM"
cik: "0001484612"
company_name: "Outset Medical, Inc."
filed_at: "2022-11-08T23:59:59+00:00"
generated_at: "2026-06-22T03:22:41.953437+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Outset Medical Q3 revenue $27.8M (+5.5% YoY); raises 2022 guidance to $111-113M

## Summary
- Revenue $27.8M, +5.5% YoY and +10.8% QoQ; gross margin 15.6% vs 11.2% YoY.
- Net loss ($40.8M) / ($0.85) per share; non-GAAP EPS ($0.70).
- Raises FY2022 revenue guidance to $111M-$113M from $105M-$110M.
- Awarded 5-year VA contract for Tablo at 106 VA hospitals and home settings.
- Secured up to $300M in debt financing to strengthen balance sheet.

## SEC filing metadata
- accession: 0000950170-22-023229
- form_type: 8-K
- ticker: OM
- cik: 0001484612
- company_name: Outset Medical, Inc.
- filed_at: 2022-11-08T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1484612/000095017022023229/0000950170-22-023229-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1484612/000095017022023229/om-20221108.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-22-023229
- JSON: https://secwatch.observer/filing/0000950170-22-023229.json
- Plain text: https://secwatch.observer/filing/0000950170-22-023229.txt

## Key facts
- Earnings Releases
  Outset Medical, Inc. reported the third quarter ended September 30, 2022 results: revenue $27.8 million, net income ($40.8) million, EPS ($0.85) per share. Guidance raised.
  - Period: the third quarter ended September 30, 2022
  - Revenue: $27.8 million
  - Net income: ($40.8) million
  - EPS: ($0.85) per share
  - Guidance: raised
  - Result: reported results
  source text: specific reference in such a filing. --- EX-99.1 (EX-99.1) --- EX-99.1 Exhibit 99.1 Outset Medical Reports Third Quarter 2022 Financial Results Revenue Grows 10.8% from Q2 to $27.8 million; Gross Margin Expands to 15.6% 2022 Revenue Guidance Raised to $111 million to $113 million San Jose, CA – November 8, 2022 – Outset Medical, Inc. (Nasdaq: OM) (“Outset” or the
  evidence_url: https://www.sec.gov/Archives/edgar/data/1484612/000095017022023229/0000950170-22-023229-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.